{"meta":{"query_hash":"fedd65a2603b","filters":{"venue":"Pharmaceutical Drug Regulatory Affairs Journal"},"cohort_total":4,"direct_labels_cover":0,"predictions_cover":4,"exported":4,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/fedd65a2603b","api":"https://metacan.xera.ac/api/v1/cohort?venue=Pharmaceutical+Drug+Regulatory+Affairs+Journal"},"results":[{"id":"W4296654187","doi":"10.23880/pdraj-16000105","title":"Generic Drugs: The Landscape is Evolving So are the Mentalities?","year":2018,"lang":"en","type":"article","venue":"Pharmaceutical Drug Regulatory Affairs Journal","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Geography","score_opus":0.05306494190187391,"score_gpt":0.2984594521955941,"score_spread":0.2453945102937202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296654187","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006251324,0.027508618,0.0014948903,0.9488918,0.0015315708,0.0000088023535,0.0003313137,0.000037713067,0.013943933],"genre_scores_gemma":[0.298408,0.11821787,0.004491034,0.5491522,0.020930937,0.00006248744,0.0005967852,0.0001910958,0.007949605],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926939,0.0030613837,0.00036746432,0.00093987695,0.001611769,0.0013255684],"domain_scores_gemma":[0.97252357,0.009577737,0.003150782,0.0012478381,0.006238596,0.0072615375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01761428,0.00057819753,0.0010619127,0.0020270902,0.0027350865,0.016920744,0.0025265529,0.011814729,0.019075835],"category_scores_gemma":[0.027986854,0.00051294145,0.0010058959,0.0029300817,0.010907913,0.020283189,0.003547464,0.014199853,0.0030991605],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005541512,0.00029237077,0.018833242,0.0010991445,0.00025424152,0.00049833505,0.0017857063,0.0017436203,0.001251423,0.41653287,0.32917598,0.22797891],"study_design_scores_gemma":[0.00011486924,0.00024700272,0.025490532,0.0022154765,0.00010653131,0.0009166515,0.006356045,0.0015577272,0.0004233651,0.3981932,0.564079,0.0002994768],"about_ca_topic_score_codex":0.012386165,"about_ca_topic_score_gemma":0.019573981,"teacher_disagreement_score":0.019075835,"about_ca_system_score_codex":0.007920125,"about_ca_system_score_gemma":0.010386535,"threshold_uncertainty_score":0.09315431},"labels":[],"label_agreement":null},{"id":"W4296654245","doi":"10.23880/pdraj-16000101","title":"Do’s and Don’ts in Early Drug Development","year":2018,"lang":"en","type":"article","venue":"Pharmaceutical Drug Regulatory Affairs Journal","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Druggability; Drug development; Drug; Engineering ethics; Drug discovery; Business; Risk analysis (engineering); Medicine; Nanotechnology; Pharmacology; Engineering; Biology; Bioinformatics; Genetics","score_opus":0.019273805670373633,"score_gpt":0.3034430668433455,"score_spread":0.28416926117297187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296654245","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062929173,0.14533208,0.019959375,0.5553428,0.030349808,0.00017584676,0.00021914598,0.00042571765,0.2419023],"genre_scores_gemma":[0.28850967,0.16893098,0.03158764,0.36063668,0.022494867,0.00063974864,0.00030732484,0.0006864267,0.12620662],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9788931,0.011454382,0.0009628613,0.0018751605,0.0054933596,0.001321123],"domain_scores_gemma":[0.95935,0.02780451,0.0022757933,0.0033213454,0.003651627,0.0035967522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.032097675,0.00068190345,0.0010341943,0.0013427946,0.0032921047,0.010322485,0.001636758,0.00573123,0.014087171],"category_scores_gemma":[0.045121714,0.000505658,0.0006220713,0.001494458,0.020932417,0.017102446,0.005175977,0.010776645,0.0061176764],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016728672,0.00012553236,0.0016943841,0.00091828173,0.000031108564,0.00038920005,0.002361791,0.00029675692,0.0004206707,0.69832,0.11433269,0.18094234],"study_design_scores_gemma":[0.000020312458,0.00010571156,0.00033164775,0.0006531366,0.000013409475,0.00039384782,0.0010016742,0.00018322229,0.00043070366,0.18136975,0.81547004,0.000026605489],"about_ca_topic_score_codex":0.0018962033,"about_ca_topic_score_gemma":0.0026667311,"teacher_disagreement_score":0.032097675,"about_ca_system_score_codex":0.004820858,"about_ca_system_score_gemma":0.0050843363,"threshold_uncertainty_score":0.16975081},"labels":[],"label_agreement":null},{"id":"W4296654249","doi":"10.23880/pdraj-16000108","title":"Filing of DMF in US, Canada & Europe","year":2019,"lang":"en","type":"article","venue":"Pharmaceutical Drug Regulatory Affairs Journal","topic":"Pharmaceutical Quality and Counterfeiting","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Confidentiality; License; Quality (philosophy); Product (mathematics); Business; Computer science; Database; Law; Political science; Computer security; Mathematics","score_opus":0.032878844108487126,"score_gpt":0.3294791601175436,"score_spread":0.29660031600905645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296654249","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033945765,0.014079168,0.012588539,0.008273409,0.0027009775,0.0022468544,0.042139463,0.0037665986,0.8802591],"genre_scores_gemma":[0.14997055,0.024008412,0.04187486,0.007302974,0.00079696474,0.00082049734,0.0582674,0.0022223229,0.71473604],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99164927,0.00028239086,0.00040184238,0.00056306145,0.0060365847,0.0010668677],"domain_scores_gemma":[0.9865232,0.0008230164,0.0006878846,0.0008808848,0.01044922,0.0006357513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041432185,0.00056568556,0.00059600663,0.008089712,0.0051604453,0.0056941756,0.0015983445,0.0016224972,0.049748242],"category_scores_gemma":[0.013129092,0.00041939996,0.0006595121,0.006839792,0.0016836493,0.0015998122,0.0020412947,0.0015031463,0.022489903],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022885735,0.000101605976,0.0086361,0.0006595124,0.00003164727,0.0010883269,0.0012537662,0.00045077817,0.006746861,0.04766709,0.63106954,0.30206585],"study_design_scores_gemma":[0.000008258767,0.000020019743,0.010846673,0.00029393387,0.000011381218,0.0002444551,0.00033182427,0.00012886265,0.0035415506,0.00039590607,0.984148,0.000029148061],"about_ca_topic_score_codex":0.63313335,"about_ca_topic_score_gemma":0.59652895,"teacher_disagreement_score":0.36686665,"about_ca_system_score_codex":0.01611434,"about_ca_system_score_gemma":0.05372631,"threshold_uncertainty_score":0.7380544},"labels":[],"label_agreement":null},{"id":"W4297910174","doi":"10.23880/pdraj-16000135","title":"Regulatory Affairs: More than Guidance and Guidelines","year":2022,"lang":"en","type":"article","venue":"Pharmaceutical Drug Regulatory Affairs Journal","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre for Drug Research and Development","funders":"","keywords":"Regulatory affairs; Political science; Veterans Affairs; Public administration; Medicine; Internal medicine","score_opus":0.29162020057941596,"score_gpt":0.4523691651366288,"score_spread":0.16074896455721283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297910174","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033961856,0.02460356,0.005406308,0.92408204,0.015641475,0.000076089855,0.00016174892,0.00023706451,0.02945216],"genre_scores_gemma":[0.0150893545,0.021904564,0.018564604,0.8959339,0.022022998,0.00046281586,0.0004305047,0.00037469732,0.02521653],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.83984536,0.07206032,0.016300341,0.007113206,0.059701383,0.0049794125],"domain_scores_gemma":[0.72364783,0.14527206,0.01960615,0.015123451,0.08431084,0.012039701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.11909159,0.0016534636,0.004034815,0.0047457786,0.0046986328,0.025227422,0.0056930445,0.05266071,0.0070671677],"category_scores_gemma":[0.22413255,0.0019577586,0.001991611,0.0048406776,0.019989066,0.020562993,0.0063980226,0.05465375,0.006407527],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016191441,0.000079829115,0.00019118385,0.00027852337,0.000019854197,0.000047796053,0.0003360771,0.0002043744,0.000104302344,0.11002496,0.8585989,0.030098025],"study_design_scores_gemma":[0.000059832546,0.000033282173,0.0007038929,0.0026591255,0.000031065,0.000118687385,0.0004222596,0.0003525143,0.00012050689,0.097612984,0.89780086,0.00008505802],"about_ca_topic_score_codex":0.013369928,"about_ca_topic_score_gemma":0.02040239,"teacher_disagreement_score":0.11909159,"about_ca_system_score_codex":0.007828664,"about_ca_system_score_gemma":0.043090325,"threshold_uncertainty_score":0.62982404},"labels":[],"label_agreement":null}]}